Upon differentiating between SSR4+ and SSR4- cells, SSR4 may regulate the intricate interaction network between ESCC plasma cells and other cells within the TME, potentially through modulation of the MIF/CD74/CXCR4 pathway. This evidence concerns the gene SSR4 and esophageal squamous cell carcinoma.